Call for Abstracts - HOPA Annual Conference 2026
Research posters are core to the science we share at our annual conferences! We want you - and your research - to join us at HOPA Annual Conference 2026, taking place March 25-27, 2026 in New Orleans, Louisiana.
Abstract Submissions Schedule
| Opens | Closes | |
| Completed Research | July 17, 2025 | September 25, 2025 |
| Late-Breaking Research | October 13, 2025 | November 10, 2025 |
| Trainee Research | October 13, 2025 | January 4, 2026 |
Read the Submission Criteria here
Types of Research Posters
Click the research type for more information and for access to the submission portal.
- Completed Research - CLOSED
Research that has been studied, tested, and has results and conclusions available for presentation.
- Late Breaking Research - CLOSED
Incomplete results at the Completed Research deadline, but is now able to be presented with results and conclusions.
- Trainee Research - Open now!
A student, resident, or fellow, must be the primary and presenting author of the abstract being submitted.
Tips for Submitting Abstracts
All abstracts must be submitted by the deadline, as late entries will not be considered. Abstracts should be no more than 400 words and must include the following required elements:
- Background
- Objectives
- Methods
- Results
- Conclusion/Discussion
Review articles and single case reports will not be accepted.
For a more detailed description of these tips, click here.
Selected completed research abstracts will be published in the Journal of Hematology/Oncology Pharmacy (JHOP), HOPA's official peer-reviewed forum for oncology pharmacy practice.
For more details, author requirements, and full abstract submission criteria, click here.
Poster Specifications
Please review poster specifications for both Traditional and ePosters and follow the naming conventions. You can also find presentation tips within here:
HOPA Poster Guidelines and Specifications
Poster Deadlines for ACCEPTED Abstracts*
- Window to submit Trainee e-posters for Trainee Award consideration: January 19 - February 2, 2026 (completed results required for consideration)
- Window to submit all other accepted poster files (non-award): March 12, 2026
- HOPA Annual Conference: March 25-27, 2026 | New Orleans, LA
*Deadlines apply only to authors who have already submitted an abstract during the Abstract Submission windows, and have been notified by HOPA that their abstract has been accepted.
Quality Research Certificate
The Quality Research Certificate is an award presented by the Quality Oversight Committee at each Annual Conference that celebrates exemplary research focused on quality care in oncology. Strong candidate abstracts include the following criteria:
- Focus on quality and value metrics in the care of patients with cancer
- Project results have an impact on the current practice of cancer care, with a potential for broader impact beyond one single organization
- Address a nationally or internationally recognized oncology and/or pharmacy quality metric or standard, such as ASCO QOPI or COC
- Highlight the role and/or value of the pharmacist in the delivery of care to oncology patients
To have a research abstract considered for the Quality Research Certificate, the abstract must be submitted to the Annual Conference and be self-identified as a Quality Improvement research project. Trainee, Late Breaking, and Completed Research abstracts are all eligible for consideration. The HOPA Quality Oversight Committee completes a competitive peer review process and selects up to five certificate winners. The winning abstracts are also highlighted in a HOPA News column following the Conference.
Authorship
Abstract presenting authors do not need to be a HOPA member in order to be considered for a poster presentation at the HOPA Annual Conference. However, the presenting author must be a HOPA member and must also be the principal or co-principal investigator of the research in order to be considered for a platform or award-seeking presentation, or to present an industry-sponsored poster.. Please see definitions below.
Please note that presenting authors are required to attend the conference and present during the poster session.
Research presented at other professional meetings will be considered for “Encore” presentations. Encore presentations are not eligible for HOPA abstract/poster awards, Late-Breaking research or platform presentation of their work.
Industry
Industry Encore Posters are posters that have been accepted and presented at other professional meetings and/or previously published and are submitted by one of HOPA’s Industry Relations Council (IRC) Partners.
Industry Supported Abstracts are eligible for presentation at the HOPA Annual Conference as Completed Research, Late-Breaking Research, and “Encore” Research. The presenting author for industry sponsored abstracts must be a HOPA member. An industry employee may not present research at the HOPA Annual Conference unless they acted as a primary investigator on the project. All financial interests and commercial or federal funded research must be disclosed upon submission.
ePosters
An electronic poster (ePoster) is an electronic submission of the poster to be presented at the annual meeting. Selected authors (Completed Research, Late-Breaking Research, and those applying for Trainee Top Ten) will create and submit an ePoster according to the guidelines of acceptance and upload the final version to a specified website for reviewing. Initial ePosters will be due approximately four to six weeks prior to the meeting, and final ePosters will be due approximately two weeks prior to allow time for off-site review. Further details and information will be communicated with the accepted presenter regarding the electronic poster process upon notification of abstract acceptance.
Avoidance of Commercialism
All presentations must avoid commercialism. Presentations that constitute promotion and advertising (including the use of logos) will not be considered. If the cost of any presentation has been underwritten to any extent, a clear acknowledgment stating the support, identifying the source, and describing the methods for keeping the content unbiased should be included. Advertising material that in any way promotes the commercial interest of a particular company, enterprise, or the author(s) may not be distributed or displayed. Statements made in the presentation are the sole responsibility of the author and are not viewed as, or considered representative of, any formal position taken on any product, subject, issue or by HOPA.
Responsibility for Expenses
The HOPA Annual Conference gives hematology/oncology pharmacy professionals the opportunity to present their work within an atmosphere of support by peers and national leaders. Presenters must register for at least the day on which they are scheduled to present. Only those presenters (or representatives) committed to attending the conference may submit an abstract. Presenters are responsible for all expenses such as travel, hotel, and meeting registration fees.
Abstract Embargo Policy
HOPA's embargo policy states that coverage of research abstracts being presented at the Annual Conference is strictly prohibited until two weeks before the conference. Content that is previously published online, in advance of print publication, is still subject to HOPA's embargo policy.
